Xenetic Biosciences Inc (XBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.89M
Last updated: Nov 17, 2026 at 8:24 AM ET
Xenetic Biosciences Inc (XBIO) Competitors
The companies most similar to Xenetic Biosciences are XTL Biopharmaceuticals Ltd ADR (XTLB), Curis (CRIS) and PharmaCyte Biotech (PMCB). By market cap, Xenetic Biosciences ranks 7th of the 13 companies on this page; Cadrenal Therapeutics, Inc. Common Stock (CVKD) is the largest at $5.39M.
Peer Comparison
XBIO's revenue growth of 12.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Xenetic Biosciences (XBIO) | $3.89M | N/A | 1.2x | -75.9% | N/A | 12.0% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Azitra Inc (AZTR) | $3.69M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| XORTX Therapeutics Inc (XRTX) | $2.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.39M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $3.89M | N/A | 4.0x | 0.0% | -1322.8% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Xenetic Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| XTL Biopharmaceuticals Ltd ADR (XTLB) | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| Azitra Inc (AZTR) | Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live... | AZTR competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Senti Biosciences Inc (SNTI) | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| XORTX Therapeutics Inc (XRTX) | XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease... | XRTX competitors |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated... | CVKD competitors |
Frequently Asked Questions About XBIO
Who are Xenetic Biosciences' main competitors?
The companies most similar to Xenetic Biosciences include XTL Biopharmaceuticals Ltd ADR (XTLB), Curis (CRIS), PharmaCyte Biotech (PMCB), CNS Pharmaceuticals (CNSP) and Creative Medical Technology Holdings (CELZ), listed from the closest match.
Who is Xenetic Biosciences' biggest competitor?
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is the largest of the similar companies at $5.39M; XTL Biopharmaceuticals Ltd ADR (XTLB) is the closest match by business profile, size, sector and industry.
How does XBIO stock compare with its competitors?
XBIO's P/S is 1.2x against a peer median of 4.0x; its net margin is -75.9% against a peer median of 0.0%.
Which of Xenetic Biosciences' competitors pays a higher dividend?
Xenetic Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Xenetic Biosciences bigger than its competitors?
No. Xenetic Biosciences is 7th by market cap among the 13 companies on this page; the largest is Cadrenal Therapeutics, Inc. Common Stock (CVKD) at $5.39M.
XBIO pages: Overview, Earnings, Forecast, Financials, Competitors